Sudarshan Pharma Industries has entered into a Technology Transfer Agreement dated January 24, 2025 with Uttaranchal University, Dehradun and taken the rights, interest and ownership of Patent (Preparation of Bioplastic from Stubble of Rice, Aloe Vera waste, PVA And Glycerol plasticizer), published by the Government of India, The patent Office.
As per the Agreement, the company has taken the rights, interest and ownership in aforesaid Patents shall vest exclusively with the company for a period of 5 years commencing from January 24, 2025.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1695.20 |
| Dr. Reddys Lab | 1221.70 |
| Cipla | 1230.25 |
| Zydus Lifesciences | 940.05 |
| Lupin | 2316.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: